This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A federal judge in New Jersey ruled that five of Teva’s patents on the metered dose inhaler for its asthma med ProAir HFA are “improperly listed” in the FDA’s Orange Book. The ruling came in Teva's case against Amneal Pharmaceuticals, which is seeking to launch a generic version of the drug.
Solv has added direct real-time booking to Solv Connect, its marketplace for same-day and next-day healthcare appointments. This announcement decouples Solv Connect from the company’s other software offering, Solv Experience, which is its practice management platform.
With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in a bid to boost production for a long-approved transplant treatment and a | Sanofi has unveiled a 40 million euro investment at its Lyon Gerland biomanufacturing site in France.
The Federal Trade Commission says more than 100 patents from 10 biopharma companies are improperly listed in the FDA’s official publication of approved products. Such listings delay generic competition, which reduces consumer choice and keeps prices high, the regulator said.
Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. ZoomInfo customers aren’t just selling — they’re winning. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line.
With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one. Following a string of high-profile deals, Samsung Biologics has locked down a $1.2 billion contract with an unnamed Asia-based pharmaceutical company that’s expected to run through December 2037.
After a clutch of lawmakers last month challenged “sham patents” registered with the FDA’s Orange Book—the registry for patents of approved drugs—the Federal Trade Commission (FTC) is getting in on | After multiple lawmakers last month challenged “sham patents” registered with the FDA’s Orange Book, the FTC is getting in on the action.
And for those in the sales profession, sales books are one easily accessible way to engage in continual learning, even when you’re on the road. To help you narrow it down, we have compiled a selection of some of the best sales books (in our opinion) to read this summer, starting with two from Integrity Solutions.
Pfizer’s $43 billion acquisition of Seagen is in the books, the company said on Thursda | It’s a done deal. Pfizer’s $43 billion acquisition of Seagen is in the books, as it becomes the largest M&A transaction in the biopharma industry since AbbVie snatched up Allergan for $63 billion in 2019.
A new report found that telehealth accounted for 87% of mental health appointments booked last month. Mental health is bucking the overall trend in telehealth utilization. That percentage is continuing to climb, despite virtual care visits declining across all other specialties.
Through the collaboration, CareFirst’s individual behavioral health practitioners can join Headway’s platform so members can filter, choose a provider, book and pay in one spot.
Patients can now find and book urgent care appointments in 22 states at more than 200 facilities on Zocdoc’s marketplace. In 2023, the company saw the volume of new urgent care facilities on Zocdoc grow by nearly 40% month over month on average and urgent care bookings grow by 80% month over month on average.
Members are able to book appointments within one to two business days and receive in-person assessments of their mobility, as well as any fall hazards in their home. The in-home service is meant to complement the company’s virtual care.
With an agreement to make payments totaling $750 million over the next five years, Teva can wipe its slate clean of litigation from Israeli regulators that concerns over a decade's worth of taxes.< < | The deal with the Israel Tax Authority wraps up pending litigation over taxes payable from 2008 to 2020.
A book by Mehrnaz Campbell charts a way forward Pharma has embraced digital and omnichannel to transform sales engagement, but has little to show for the effort.
Through the partnership, patients can find and book appointments with Zaya’s providers via Zocdoc’s website or app. The partnership represents the first time Zocdoc will have lactation consultants available on its marketplace, said Dr. Oliver Kharraz, Zocdoc founder and CEO.
FTC is not done with its crackdown on what it views as improper listing of patents in the FDA Orange Book. Federal Trade Commission (FTC) is not done with its crackdown on what it views as improper listing of patents with the FDA. |
With a year and change still left before Fujifilm Diosynth cuts the ribbon on a massive biomanufacturing facility in North Carolina, the CDMO has already lined up its first client.
Patients are now able to find and book appointments with FQHCs working with Zocdoc on the company’s website or app, and can filter based on factors like specialty and location. Zocdoc, a healthcare marketplace, is adding Federally Qualified Health Centers (FQHCs) to its platform.
. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will host “Let Licensing Bloom: The Root of Responsible AI” on 17 October, 3:00 – 4:00 pm CET at the 2024 Frankfurt Book Fair in Frankfurt Studio Hall 4.0, For more information, visit the CCC booth at the 2024 Frankfurt Book Fair in Hall 4.0,
. | Only two months after the Federal Trade Commission said it was eying a crackdown on improper patents listed by the FDA, the agency has filed challenges against more than 100 patents in the agency's Orange Book. The companies have 30 days to respond.
The 2020-approved breast cancer med booked $17.9 MacroGenics’ first commercial product, breast cancer drug Margenza, is heading off to TerSera Therapeutics through a $40 million hand-off. | million in 2023 sales as it struggled to make a mark in the crowded market.
CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will host, “ Publishers, Copyright & AI: Taking Action ” at the 2024 London Book Fair on Tuesday, 12 March, 10:30 – 11:00am GMT in the Tech Theatre. March 5, 2024 – Danvers, Mass. –
Peppermint is an “online clubhouse community” for adults aged 55 and older that allows them to connect with others through online clubs (like for traveling or gardening), workshops (like for nutrition or photography) and collaboration (where members can work together on activities like creating a recipe book).
After a yearslong investigation involving politicians and medical professionals alike, Novartis is looking to close the books on its Greek bribery imbroglio. After an investigation that dates back to 2017, four former Novartis executives and a Greek politician were cleared of bribery charges.
Connect with him: LinkedIn Best Book: Founding Fathers: The Essential Guide to the Men Who Made America. He shares specific resources, proven approaches for product innovation, and the mindset shifts needed to thrive in today’s evolving healthcare landscape. Remember to subscribe to our Podcast for more valuable episodes.
After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and persuading several drugmakers to retract their intellectual property (IP) protections in the process—the U.S. When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down.
After reaching a settlement with Minnesota’s attorney general, Eli Lilly can close the book on a yearslong lawsuit in the state. | The company will provide its insulin products at $35 per month and donate free insulin at 15 clinics over the next five years. Meanwhile, Minnesota's claims against Novo Nordisk and Sanofi remain ongoing.
This is one of the reasons Mike Esterday and I were motivated to write our new book, Listen to Sell. On the contrary, one of the underlying themes that was continually reinforced for us while we wrote this book is that the role of the sales professional has never been more purposeful.
Federal Trade Commission's recent crackdown on "improper" patents in the FDA's Orange Book, GSK, Amneal and Kaleo have made the requested changes. Following the U.S. Following the U.S.
Sarasohn-Kahn tackles in her book HealthConsuming: From Health Consumer to Health Citizen. Consumers are much more comfortable shopping for a TV, a car, picking a mobile phone provider, and booking travel themselves. What if … people got a fair ROI for healthcare spending the way we expect a reasonable return from other investments?
The Federal Trade Commission is warning pharmaceutical companies that they could face legal action by making “improper” listings in the FDA’s Orange Book, a registry of patents for approved drugs.
Three months on, Eli Lilly has closed the books on its search for a new chief financial officer. And as with its previous CFO, Anat Ashkenazi, the company didn’t have to look far.
Hedley Rees has written a book on pharma supply chains that is eye-opening and downright scary. As Mr Rees writes in his book it wasn’t always like this but if we don’t get more people to listen a looming disaster is just waiting to happen. Patients should be scared.
Artificial intelligence is upending publishing, and industry leaders know theres no end in sight. Thats why they plan to win key copyright lawsuitsthen forge a path forward through Silicon Valley.
Delve into Jon’s personal story, from the influence of his author father to his own four-year endeavor of writing a book aimed at guiding future medical sales reps. Listen as we unpack the motivations and challenges behind writing his book and discuss how these experiences have shaped his professional journeys.
The 'Blue Book' Dictates Your Reach In Malaysia, the Ministry of Health’s Blue Book is the gatekeeper to government hospital sales. Pro Tip: Understand the registration process for the Blue Book and stay updated on any changes in its guidelines. How to Stand Out: Highlight your product’s cost-effectiveness and reliability.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content